Trial Terms and Conditions

Important Notices — Please Read Before Activating

1. About These Terms

1.1 These Trial Terms and Conditions ("Trial Terms") govern access to and use of the Kamios free trial ("Trial") made available by Neutrinos in connection with the ITC InsureTech Connect 2026 event ("Event").

1.2 By (a) clicking "I accept the Trial Terms and Conditions", (b) creating a login password, or (c) activating or using a Trial Tenant, you accept these Trial Terms on behalf of yourself and the organisation you represent (collectively, "you", "Customer", "Trial Participant"). By accepting, you represent that you are duly authorised to legally bind your organisation.

1.3 If you do not accept these Trial Terms in their entirety, you must not activate or use the Trial.

1.4 These Trial Terms constitute the entire agreement between the parties with respect to the Trial. No paid subscription, continuing services contract or any other commercial obligation arises from these Trial Terms.

1.5 In the event of any conflict between these Trial Terms and any other communication, marketing material, summary or representation relating to the Trial, these Trial Terms prevail.

2. Definitions

In these Trial Terms, the following expressions have the meanings ascribed to them below:

"Activation Date" means the date on which the Customer first logs in to and activates its Trial Tenant.

"AI Credits / Credits" means the promotional AI usage credits pre-loaded into the Trial Tenant, up to US$500 in value, provided solely to enable evaluation of the Platform during the Trial Period.

"Competing Product" means any product, software, service, platform or solution that is substantially similar to, or designed or intended to compete with, the Platform or any commercial product or service of Neutrinos.

"Competitor" means any entity (including its affiliates, subsidiaries and parent companies) that develops, markets, sells or provides a Competing Product, or that is actively engaged in planning to do so.

"Customer Data" means all data, content, information and materials of any nature whatsoever uploaded to, submitted to, input into, or generated within the Trial Tenant by or on behalf of the Customer during the Trial Period.

"Event" means the ITC InsureTech Connect 2026 conference held in Las Vegas, Nevada, United States of America, in October 2026.

"FDE" means a Neutrinos Forward Deployed Engineer made available remotely to support the Customer's evaluation during the Trial Period.

"Fair Usage Policy" means the fair usage policy set out in Section 8 of these Trial Terms.

"Platform" means the Kamios agentic AI orchestration platform, including all related software, models, APIs, tools, interfaces, documentation and hosted services, provided by Neutrinos.

"POC" means any proof of concept, prototype, configuration, workflow, test, output or result produced within the Trial Tenant during the Trial Period.

"Trial" means the free, time-limited evaluation access to the Platform offered by Neutrinos to participants at the Event on the terms set out in these Trial Terms.

"Trial Period" means the period commencing on the Activation Date and ending thirty (30) calendar days thereafter, or upon earlier termination pursuant to Section 17.

"Trial Tenant" means the isolated, sandboxed workspace provisioned for the Customer on the Platform, identified by a unique Tenant Code.

"Voucher / Tenant Code" means the unique code issued to a person at or in connection with the Event that entitles the holder to activate a Trial Tenant.

3. Eligibility and Activation

3.1 The Trial is open to businesses evaluating the Platform for internal purposes. To be eligible, you must:

• hold a valid, unredeemed Voucher / Tenant Code issued at or in connection with the Event;
• register using a valid corporate email address — personal or free-domain email addresses are not accepted;
• be of full legal capacity and duly authorised to bind your organisation to these Trial Terms;
• not be a Competitor and not be accessing the Trial for any purpose connected with the development, evaluation or benchmarking of a Competing Product; and
• be located in a jurisdiction in which access to the Platform is not prohibited by applicable law, export control regulations or sanctions.

3.2 Only one (1) Trial Tenant per organisation is permitted. Multiple Voucher / Tenant Codes may not be used by the same organisation or its affiliated entities.

3.3 Voucher / Tenant Codes must be redeemed and the Trial Tenant activated within thirty (30) calendar days of the last day of the Event. Codes not activated within this window expire automatically and are void.

3.4 Voucher / Tenant Codes are single-use, non-transferable and have no monetary value. They may not be sold, assigned, gifted or transferred to any third party.

3.5 Neutrinos may verify your identity and eligibility, including by issuing a one-time verification code to your registered email address or telephone number, and may decline or revoke access at any time if eligibility requirements are not, or are found not to have been, satisfied.

3.6 By activating the Trial, you represent and warrant that you and your organisation satisfy all eligibility requirements set out in this Section 3 and that all information provided during registration is true, accurate and complete. Any misrepresentation constitutes a material breach of these Trial Terms entitling Neutrinos to terminate access immediately without liability.

4. Trial Offer and Trial Period

4.1 Subject to these Trial Terms, the Trial comprises:

• AI Usage Credits: up to US$500 in AI usage credits pre-loaded into the Trial Tenant for use with the Platform during the Trial Period;
• FDE Support: remote access to a Neutrinos Forward Deployed Engineer for up to thirty (30) calendar days to support the Customer's evaluation and POC development, subject to scheduling, availability and Section 6;
• Hosted Platform Access: access to the Platform as a hosted service — no local installation is required; and
• POC Collaboration: collaborative development of a proof of concept on a use case selected by the Customer, for evaluation purposes only, subject to Section 9.

4.2 The Trial is provided free of charge. No payment method is required, no charges will be raised, and no paid subscription or contract for ongoing services is created by or arises from these Trial Terms.

4.3 The Trial ends automatically upon expiry of the Trial Period. It does not auto-renew and does not convert into any form of paid or unpaid subscription.

4.4 Any continuation of access to the Platform beyond the Trial Period, including in connection with any production deployment, requires a separate written agreement duly executed by authorised representatives of both parties. No course of dealing, continued access, ongoing engagement or other conduct creates any implied licence or right to use the Platform beyond the Trial Period.

4.5 Neutrinos may suspend or terminate the Trial earlier than the expiry of the Trial Period in accordance with Section 17.

5. AI Usage Credits

5.1 Credits are promotional credits provided solely to enable evaluation of the Platform during the Trial Period. Credits:

• are provided at no charge and have no monetary or cash value;
• are non-transferable and may not be sold, assigned, shared, pooled across organisations or gifted;
• cannot be redeemed for cash, refunded, exchanged, carried forward or applied to any paid service;
• are allocated on a per-Trial-Tenant basis; and
• expire automatically, without compensation, upon expiry or earlier termination of the Trial Period.

5.2 Usage of the Platform consumes Credits as metered by Neutrinos. Neutrinos' records of Credit consumption are conclusive absent manifest error. There is no entitlement to additional or replacement Credits should the initial allocation be exhausted before the end of the Trial Period.

5.3 Credits are subject to the Fair Usage Policy in Section 8. Neutrinos may, without liability, throttle, limit, suspend or revoke Credits or Platform access where usage is inconsistent with a genuine evaluation.

5.4 Any unused Credits remaining at the end of the Trial Period are automatically forfeited without compensation.

6. Forward Deployed Engineer Support

6.1 During the Trial Period, Neutrinos will make an FDE reasonably available on a remote basis to assist the Customer in scoping a use case, building toward a POC and evaluating the Platform, subject to scheduling and the FDE's reasonable availability across all trial participants.

6.2 FDE support is provided on a best-efforts, collaborative basis for evaluation purposes only and is not:

• a paid professional services, consulting, systems integration or implementation engagement;
• subject to any delivery schedule, milestone, service level or performance commitment;
• a guarantee of any specific POC outcome, deliverable or result; or
• a warranty that the Platform will meet the Customer's requirements.

6.3 The Customer is responsible for making appropriate personnel, system access and information reasonably available to enable effective FDE collaboration.

6.4 Nothing arising from FDE engagement creates any obligation on Neutrinos to provide ongoing implementation, customisation, managed services or support beyond the Trial Period.

7. Proof of Concept

7.1 Any POC developed during the Trial is produced solely for evaluation and internal assessment of the Platform's capabilities.

7.2 The POC must not be used for or relied upon in:

• live production operations of any kind;
• regulatory submissions, filings, compliance determinations or regulatory decision-making;
• underwriting, pricing, actuarial or risk assessment decisions;
• claims handling, adjudication or settlement decisions;
• lending, credit scoring, anti-money laundering or financial crime screening;
• any customer-facing process or communication; or
• any other business-critical, legally consequential or regulated purpose.

7.3 The Customer is solely responsible for any decisions made in connection with or informed by the Trial or any POC output. Neutrinos accepts no liability whatsoever for any such decisions.

7.4 Outputs generated by AI models within the Platform during the Trial may be incomplete, inaccurate or unsuitable for any particular purpose and must be independently verified before any reliance is placed upon them.

7.5 No work product, configuration, workflow or output produced by the FDE or arising from FDE engagement constitutes a professional opinion, legal advice, regulatory guidance or technical specification upon which the Customer is entitled to rely.

8. Fair Usage Policy

8.1 Purpose. The Fair Usage Policy ensures that the Trial remains available to all participants for genuine evaluation purposes and is not abused or used in a manner that is disproportionate, exploitative or inconsistent with a bona fide technology evaluation.

8.2 Permitted use. Credits and Platform access are intended for: building and evaluating a single proof of concept on the Customer's genuine use case; testing core Platform functionality relevant to that use case; access by a reasonable evaluation team; and generating representative volumes of test data and workflows proportionate to evaluation needs.

8.3 Prohibited usage patterns. The following usage patterns are prohibited and constitute a material breach of these Trial Terms:

• Automated or bulk consumption: automated scripts, bots or programs designed to consume Credits in bulk or at rates inconsistent with manual evaluation;
• Multi-organisational sharing: sharing Tenant Code credentials or Trial Tenant access across multiple unrelated organisations, affiliates or teams;
• Stress or penetration testing: stress testing, load testing, penetration testing, security scanning or performance benchmarking of the Platform without Neutrinos' prior written consent;
• Data scraping or harvesting: systematic extraction, scraping or harvesting of Platform content, model outputs or underlying data structures;
• Non-evaluation compute use: use of the Platform's compute resources for cryptocurrency mining or any purpose unrelated to the evaluation;
• Commercial operation: use of the Trial to serve external clients, generate revenue or deliver services to third parties;
• Competitive intelligence: usage aimed at benchmarking the Platform against Competing Products or generating intelligence to inform the development of a Competing Product; and
• Multiple Trial accounts: registering or activating more than one Trial Tenant for the same organisation, whether using different codes, email addresses or personnel.

8.4 Indicative thresholds. The following thresholds serve as guidelines for fair usage. Neutrinos may apply limits at its discretion based on overall system health and participant demand:

• API calls: not more than 1,000 calls per day per Trial Tenant;
• Concurrent sessions: not more than 5 concurrent user sessions per Trial Tenant;
• Data storage: not more than 5 GB within the Trial Tenant at any time;
• Workflow executions: not more than 500 automated executions per day per Trial Tenant; and
• Evaluation team: not more than 10 named users per Trial Tenant.

8.5 Enforcement. Neutrinos reserves the right to monitor usage for compliance with this Fair Usage Policy and may, without liability, issue a warning, throttle access, suspend Credits or terminate the Trial where usage is found to be in breach.

9. Customer Data and Data Responsibility

9.1 The Customer retains all ownership rights in Customer Data. The Customer grants Neutrinos a limited, non-exclusive, non-transferable licence to host, process and use Customer Data solely to provide and support the Trial during the Trial Period.

9.2 The Customer may, at its sole discretion, upload any data to the Trial environment, including data that is confidential, proprietary or otherwise sensitive in nature. The Customer does so entirely at its own risk.

9.3 The Customer is solely and exclusively responsible for:

• the classification, legality and suitability of all Customer Data;
• compliance with all applicable laws and regulations governing the processing of Customer Data, including any applicable data protection, data sovereignty, privacy, financial services and insurance sector legislation;
• obtaining all necessary consents, authorisations, licences and approvals required to upload and process Customer Data in the Trial environment;
• the adequacy of any data protection, governance or sovereignty measures the Customer considers appropriate in connection with Customer Data; and
• ensuring that the use of Customer Data in the Trial does not violate any third-party rights or applicable regulatory requirements.

9.4 Neutrinos accepts no liability whatsoever arising out of or in connection with Customer Data, including in respect of:

• the loss, corruption, unauthorised access to, disclosure of, or damage to Customer Data;
• any failure to comply with applicable data protection, data sovereignty, privacy or regulatory requirements in relation to Customer Data;
• any breach of third-party rights arising from the Customer's use of Customer Data in the Trial; or
• any regulatory action, fine, penalty or sanction imposed on the Customer in connection with its use of Customer Data in the Trial.

9.5 The Trial environment is a sandboxed evaluation environment. Neutrinos does not warrant that it provides the same level of security, availability or resilience as Neutrinos' production systems.

9.6 Neutrinos will not use Customer Data to train or fine-tune AI models for the benefit of third parties, except with the Customer's prior written consent or as strictly necessary to provide the Trial.

9.7 At expiry or earlier termination of the Trial Period, Customer Data in the Trial Tenant will be retained for thirty (30) calendar days and then permanently deleted. The Customer is solely responsible for exporting any Customer Data it wishes to retain before deletion. Neutrinos accepts no liability for loss of Customer Data following deletion at the end of the retention period.

10. Acceptable Use and Prohibited Conduct

The Customer agrees, and will ensure that all users of its Trial Tenant agree, not to:

• use the Platform for any unlawful, fraudulent, deceptive, abusive or tortious purpose;
• rely on the Trial or any POC output for any live production, regulatory-critical or business-critical purpose as set out in Section 7.2;
• represent or imply to any third party that the Trial or POC output is production-ready, enterprise-grade or certified for any regulated use;
• resell, sublicense, rent, timeshare, share or transfer the Trial, Trial Tenant, Credits or Tenant Code to any third party;
• reverse engineer, decompile, disassemble, decode or otherwise attempt to derive the Platform's source code, model weights, algorithms or underlying technology, except to the minimum extent expressly required by mandatory applicable law and only after prior written notice to Neutrinos;
• build, develop, train or assist in building any Competing Product, or use the Trial or its outputs to inform the development of a Competing Product;
• conduct competitive benchmarking or publish comparative results relating to the Platform without Neutrinos' prior written consent;
• circumvent, disable or interfere with security, access control, authentication, rate-limiting or monitoring systems of the Platform;
• introduce malware, viruses, ransomware or other malicious code into the Platform;
• probe, scan or test the vulnerability of the Platform or any connected network without Neutrinos' prior written consent;
• access or attempt to access any Trial Tenant other than the Customer's own; or
• use the Platform in violation of any applicable export control, trade sanctions, anti-corruption or anti-bribery law.

11. Competitor Exclusion and Anti-Competitive Use

11.1 The Trial is not available to Competitors. If the Customer or its organisation is a Competitor, the Customer is not eligible for the Trial and must not activate or use it. Activation by a Competitor constitutes a material breach of these Trial Terms entitling Neutrinos to terminate access immediately without liability.

11.2 The Customer specifically agrees not to:

• access the Trial for the purpose of gathering intelligence to inform the development of a Competing Product;
• allow any person employed by or engaged by a Competitor to access the Trial Tenant; or
• share Platform outputs, features, architecture details or documentation with any Competitor.

11.3 Neutrinos reserves the right to verify that the Customer is not a Competitor and to request written confirmation of non-competition. Failure to provide such confirmation within five (5) business days of a request entitles Neutrinos to suspend access pending verification.

12. Reference and Marketing Rights

12.1 By accepting these Trial Terms, the Customer unconditionally and irrevocably consents to Neutrinos using the Customer's company name, trading name and/or logo (collectively, "Customer Marks") in connection with any of the following purposes (collectively, "Marketing Use"):

• publicising that the Customer has accessed, is evaluating or has evaluated the Kamios platform;
• listing the Customer on Neutrinos' and Kamios' websites, digital properties and landing pages;
• including the Customer's name and/or logo in Neutrinos' and Kamios' marketing and promotional materials, presentations, pitch decks and collateral;
• referencing the Customer in press releases, media communications, social media posts and investor materials; and
• using the Customer's name as a reference account in sales and business development activities.

12.2 The consent granted in Section 12.1 does not extend to: (a) the creation or publication of any case study, testimonial, quote or detailed description of the Customer's specific use case or business outcomes without the Customer's prior written approval; or (b) any use that materially misrepresents the nature or outcome of the Customer's evaluation.

12.3 The Customer may withdraw the consent granted in Section 12.1 at any time by providing written notice to marketing@kamios.ai. Withdrawal of consent shall take effect within thirty (30) days of receipt of such notice and shall not require the removal of marketing materials already published or distributed prior to receipt of notice.

12.4 No goodwill arising from Neutrinos' use of the Customer Marks pursuant to this Section 12 shall accrue to Neutrinos. All such goodwill accrues exclusively to the Customer.

13. Intellectual Property

13.1 The Platform, including all software, source code, object code, AI models and model weights, algorithms, APIs, databases, documentation, interfaces, know-how, designs and all related intellectual property rights, is and remains the exclusive property of Neutrinos and its licensors. Nothing in these Trial Terms transfers or assigns any intellectual property rights in the Platform to the Customer.

13.2 Subject to the Customer's compliance with these Trial Terms, Neutrinos grants the Customer a limited, non-exclusive, non-transferable, non-sublicensable, revocable licence to access and use the Platform solely for internal evaluation during the Trial Period. No broader rights are granted, whether expressly or by implication.

13.3 The Customer retains ownership of Customer Data and, to the extent that any POC output constitutes an original work authored solely by the Customer, of the business content of that output. Neutrinos retains all rights in the Platform functionality, model weights, inference outputs and underlying technology used to generate any POC output.

13.4 The Kamios and Neutrinos names, logos, trade marks, service marks and trade dress are the exclusive property of Neutrinos and may not be used by the Customer without Neutrinos' prior written consent.

14. Feedback

If the Customer or any of its users provides suggestions, ideas, enhancement requests, recommendations, bug reports, comments or other feedback regarding the Trial or the Platform ("Feedback"), the Customer grants Neutrinos a perpetual, irrevocable, worldwide, royalty-free, fully paid-up, sublicensable and transferable licence to use, incorporate, modify, reproduce, distribute, commercialise and exploit such Feedback in any manner and for any purpose, without restriction, compensation or attribution to the Customer. The Customer waives any moral rights in the Feedback to the fullest extent permitted by applicable law.

15. No Warranty

15.1 The Trial, the Platform and all related services, including FDE support and any POC output, are provided strictly "AS IS", "AS AVAILABLE" and "WITH ALL FAULTS", for evaluation purposes only.

15.2 To the fullest extent permitted by applicable law, Neutrinos expressly disclaims all warranties, representations, conditions and guarantees, whether express, implied, statutory or otherwise, including:

• any implied warranty of merchantability, satisfactory quality or fitness for a particular purpose;
• any warranty of non-infringement;
• any warranty that the Platform will be accurate, complete, reliable, timely, uninterrupted or error-free;
• any warranty that the Platform will meet the Customer's requirements; and
• any warranty arising from course of dealing, course of performance or usage of trade.

15.3 The Customer acknowledges that the Platform incorporates AI and machine learning models whose outputs may be unpredictable, inconsistent, biased, incomplete or inaccurate. Such characteristics are inherent in the nature of current AI systems and do not constitute a defect in the Platform.

15.4 The Trial environment is an evaluation-grade environment and is not represented to be equivalent to any production or commercially deployed version of the Platform.

16. No Service Levels or Support Obligations

16.1 No service level agreement, uptime commitment, availability guarantee, response time commitment or support obligation of any kind applies to the Trial, save only as expressly stated in these Trial Terms.

16.2 In particular, Neutrinos does not commit to any minimum level of Platform availability or uptime, response time to support queries, FDE availability beyond reasonable scheduling efforts, or data recovery or backup in the event of data loss.

16.3 Neutrinos may, at any time and without liability, conduct maintenance, updates or changes to the Platform that may result in temporary unavailability or changes to functionality.

17. Limitation of Liability

17.1 To the fullest extent permitted by applicable law, Neutrinos shall have no liability whatsoever to the Customer or any third party arising out of or in connection with: (a) the Trial; (b) these Trial Terms; (c) the Platform or any part thereof; (d) Customer Data, including its loss, corruption, unauthorised disclosure or processing; (e) any POC or output generated during the Trial; (f) FDE support or the absence thereof; or (g) any act, omission, error or delay of Neutrinos in connection with the foregoing.

17.2 Without limiting Section 17.1, Neutrinos excludes, to the fullest extent permitted by applicable law, all liability for any indirect, incidental, special, exemplary, consequential, punitive or enhanced damages, and for any loss of profits, revenue, business, anticipated savings, goodwill, data or opportunity, however arising and whether in contract, tort (including negligence or breach of statutory duty), strict liability, statute or otherwise.

17.3 To the extent that any liability of Neutrinos cannot be wholly excluded under applicable law, Neutrinos' total aggregate liability to the Customer arising out of or in connection with the Trial and these Trial Terms shall not exceed US$100 (one hundred United States dollars). The Customer acknowledges that this limitation reflects the fact that the Trial is provided free of charge, is of an evaluation nature only, and that this allocation of risk is reasonable and forms an essential part of the basis on which Neutrinos offers the Trial.

17.4 Nothing in these Trial Terms excludes or limits liability for fraud or fraudulent misrepresentation, or for any other matter in respect of which liability cannot lawfully be excluded or limited under applicable law.

17.5 The limitations and exclusions in this Section 17 apply regardless of the form of the claim and are fundamental to the agreement between the parties. Neutrinos would not offer the Trial on these terms in the absence of such limitations and exclusions.

18. Indemnification

18.1 The Customer shall defend, indemnify and hold harmless Neutrinos and its officers, directors, employees, contractors, agents, licensors and affiliates (the "Neutrinos Indemnitees") from and against any and all third-party claims, demands, actions, proceedings, losses, damages, costs and expenses, including reasonable legal fees, arising out of or relating to:

• any breach by the Customer of any provision of these Trial Terms;
• Customer Data, including its content, accuracy, lawfulness, and the Customer's authority to provide it to Neutrinos;
• the Customer's use of the Platform or the Trial in violation of any applicable law or regulation or any third-party right;
• any regulatory investigation, action, fine or penalty arising from the Customer's use of Customer Data or the Trial in a regulated context; and
• any claim by a third party arising from the Customer's uploading or processing of any data in the Trial environment.

18.2 Neutrinos will promptly notify the Customer of any claim subject to indemnification and will cooperate with the Customer in the defence of such claim. Neutrinos retains the right to participate in the defence at its own expense. The Customer may not settle any claim in a manner that imposes any obligation or liability on Neutrinos without Neutrinos' prior written consent.

19. Suspension, Termination and Effect

19.1 Either party may terminate the Trial at any time by providing written notice to the other party.

19.2 Neutrinos may suspend or terminate the Customer's access immediately and without liability in the event of:

• any breach of these Trial Terms, including the Acceptable Use provisions in Section 10, the Competitor restrictions in Section 11 and the Fair Usage Policy in Section 8;
• misrepresentation of eligibility;
• any use that Neutrinos reasonably considers poses a security, legal or regulatory risk; or
• the Customer's insolvency or the commencement of any insolvency or administration proceedings.

19.3 Neutrinos may discontinue the Trial program in its entirety at any time. Where reasonably practicable, Neutrinos will provide advance notice to active trial participants.

19.4 Upon expiry or termination of the Trial for any reason: (a) the Customer's access to the Platform and Trial Tenant ceases immediately; (b) all remaining Credits are forfeited; (c) the Customer must immediately cease use of the Platform and delete any downloaded Platform documentation or outputs; (d) Customer Data is handled in accordance with Section 9.7; and (e) the following provisions survive termination: Sections 2, 8, 11, 12, 13, 14, 15, 17, 18, 20, 22 and 23.

20. Production Use Requires Separate Agreement

20.1 These Trial Terms govern free trial access only. Any use case, proof of concept, workflow or output developed during the Trial that the Customer wishes to deploy in a live, commercial or production environment requires a separate written agreement to be negotiated and duly executed by authorised representatives of both parties.

20.2 Neither the Trial nor these Trial Terms confer any right, licence, entitlement or expectation of production use of the Platform. The Customer may not deploy any part of the Trial environment, Trial Tenant configuration or POC in a production setting without entering into such a separate agreement.

20.3 Neither party is under any obligation to enter into any further commercial agreement following the Trial. The Trial is not an offer capable of acceptance for ongoing services, and any commercial relationship requires a separate written agreement.

21. Export Controls and Sanctions

21.1 The Platform and related technology may be subject to export control laws and regulations of the United States of America, Singapore, the European Union and other applicable jurisdictions. The Customer represents and warrants that:

• it is not located in, organised under the laws of, or a national or resident of any country or territory subject to comprehensive trade sanctions or embargoes maintained by the United States, European Union, United Kingdom, United Nations or Singapore;
• it is not named on any restricted-party or denied-party list maintained by any relevant governmental authority; and
• its use of the Trial will comply with all applicable export control, trade sanctions, anti-bribery and anti-corruption laws, including the US Foreign Corrupt Practices Act and the UK Bribery Act 2010.

22. Communications

22.1 Neutrinos will contact the Customer regarding the Trial, including for activation, verification, FDE scheduling and Trial status updates.

22.2 Where the Customer has separately given consent on the registration form, Neutrinos may also contact the Customer regarding Kamios and Neutrinos products, services and events. The Customer may withdraw such consent at any time by emailing privacy@kamios.ai, without affecting its right to continue the Trial.

23. Changes to These Trial Terms

Neutrinos may modify these Trial Terms, or change or discontinue the Trial program, at any time. Where material changes affect an active Trial, Neutrinos will use reasonable efforts to provide advance notice by email to the Customer's registered address. Continued use of the Trial after notice of changes constitutes acceptance of the updated Trial Terms.

24. Governing Law and Dispute Resolution

24.1 These Trial Terms are governed by and construed in accordance with the laws of the State of Delaware, United States of America, without regard to its conflict-of-laws provisions.

24.2 The parties shall first attempt in good faith to resolve any dispute arising out of or in connection with these Trial Terms through senior-level negotiation within thirty (30) days of written notice of the dispute.

24.3 If a dispute is not resolved through negotiation, it shall be finally resolved by binding arbitration administered by the American Arbitration Association under its Commercial Arbitration Rules, before a single arbitrator, conducted in English in New York, New York. The arbitral award shall be final and binding, and judgment may be entered in any court of competent jurisdiction.

24.4 Notwithstanding the foregoing, either party may seek emergency injunctive or other equitable relief in any court of competent jurisdiction to prevent actual or threatened breach of Section 11 (Competitor Exclusion) or Section 13 (Intellectual Property).

24.5 To the fullest extent permitted by applicable law, the Customer waives any right to bring claims as a plaintiff or class member in any class action or collective proceeding arising from these Trial Terms.

25. General Provisions

25.1 Entire agreement. These Trial Terms constitute the entire agreement between the parties with respect to the Trial and supersede all prior and contemporaneous agreements, representations and understandings relating to the subject matter hereof.

25.2 Assignment. The Customer may not assign, transfer or delegate any right or obligation under these Trial Terms without Neutrinos' prior written consent. Neutrinos may assign these Trial Terms to an affiliate or in connection with a merger, acquisition or sale of assets, on notice to the Customer.

25.3 Severability. If any provision of these Trial Terms is held to be invalid or unenforceable, that provision shall be modified to the minimum extent necessary to make it enforceable, and the remaining provisions shall continue in full force and effect.

25.4 No waiver. Failure or delay by either party to enforce any provision or exercise any right does not constitute a waiver of that provision or right. A waiver is effective only if given in writing.

25.5 Force majeure. Neither party shall be liable for any delay or failure to perform resulting from circumstances beyond its reasonable control, including acts of God, government action, internet infrastructure outages or cyberattacks, provided the affected party promptly notifies the other and uses reasonable efforts to mitigate the impact.

25.6 Relationship of parties. The parties are independent contractors. These Trial Terms create no partnership, joint venture, agency, employment or fiduciary relationship.

25.7 Notices. Notices to Neutrinos shall be sent to trial@kamios.ai. Legal notices to Neutrinos shall be addressed to legal@neutrinos.com. Notices to the Customer shall be sent to the email address associated with its Trial Tenant registration.

25.8 Electronic contracting. The Customer agrees that acceptance of these Trial Terms by electronic means, including by clicking "I accept", constitutes a valid and legally binding agreement having the same effect as a handwritten signature.

25.9 Third-party rights. These Trial Terms do not confer any benefit or right on any third party.

25.10 Language. These Trial Terms are in English. In the event of any conflict between an English version and any translation, the English version prevails.

26. Contact Information